FMR LLC 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 09:37 am Sale | 2023-04-06 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 40,444 0.050% | -4,613,009 (-99.13%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 4,653,453 6.050% | -3,019,220 (-39.35%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 7,672,673 9.999% | -88,912 (-1.15%) | Filing |
| 2021-04-12 1:05 pm Unchanged | 2021-04-09 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 7,761,585 10.116% | 0 (Unchanged) | Filing |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 7,761,585 9.999% | -148 (-0.00%) | Filing |
| 2020-12-10 09:15 am Purchase | 2020-12-09 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 7,761,733 10.000% | 7,761,733 (New Position) | Filing |